Health
Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects – News-Medical.Net
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor…
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy, to reduce the severity of treatment side effects that sometimes occur. This advance was seen in a patient enrolled in a clinical trial using CAR-T to treat refractory acute B-cell leukemia. It demonstrates a proof-of-principle for possible expanded use of CAR-T immunotherapy paired with the…
-
Noosa News18 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General14 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate
-
Noosa News22 hours agoTeenager sentenced to 12 years for ‘heinous’ Acacia Ridge murder
-
Noosa News20 hours agoGirl’s death in a Queensland cult